BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15742383)

  • 1. The target discovery process.
    Egner U; Krätzschmar J; Kreft B; Pohlenz HD; Schneider M
    Chembiochem; 2005 Mar; 6(3):468-79. PubMed ID: 15742383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rational approach to maximize success rate in target discovery.
    Schneider M
    Arch Pharm (Weinheim); 2004 Dec; 337(12):625-33. PubMed ID: 15597396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule kinase-inhibitor target assessment.
    Kung C; Shokat KM
    Chembiochem; 2005 Mar; 6(3):523-6. PubMed ID: 15696508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic methods for drug target discovery.
    Sleno L; Emili A
    Curr Opin Chem Biol; 2008 Feb; 12(1):46-54. PubMed ID: 18282485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide aptamers as guides for small-molecule drug discovery.
    Baines IC; Colas P
    Drug Discov Today; 2006 Apr; 11(7-8):334-41. PubMed ID: 16580975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies and methods in the identification of antagonists of protein-protein interactions.
    Gadek TR
    Biotechniques; 2003 Jun; Suppl():21-4. PubMed ID: 12813901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target deconvolution strategies in drug discovery.
    Terstappen GC; Schlüpen C; Raggiaschi R; Gaviraghi G
    Nat Rev Drug Discov; 2007 Nov; 6(11):891-903. PubMed ID: 17917669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of potential drug targets based on simple sequence properties.
    Li Q; Lai L
    BMC Bioinformatics; 2007 Sep; 8():353. PubMed ID: 17883836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SAR by ILOEs: an NMR-based approach to reverse chemical genetics.
    Becattini B; Pellecchia M
    Chemistry; 2006 Mar; 12(10):2658-62. PubMed ID: 16121405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated expressional analysis: application to the drug discovery process.
    Ilyin SE; Horowitz D; Belkowski SM; Xin H; Eckardt AJ; Darrow AL; Chen C; Maley D; D'Andrea M; Plata-Salamán CR; Derian CK
    Methods; 2005 Nov; 37(3):280-8. PubMed ID: 16308157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of successful drug discovery and development.
    Pauwels R
    Antiviral Res; 2006 Sep; 71(2-3):77-89. PubMed ID: 16828174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of ESI-MS in drug discovery: interrogation of noncovalent complexes.
    Hofstadler SA; Sannes-Lowery KA
    Nat Rev Drug Discov; 2006 Jul; 5(7):585-95. PubMed ID: 16816839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for targeting protein-protein interactions with synthetic agents.
    Yin H; Hamilton AD
    Angew Chem Int Ed Engl; 2005 Jul; 44(27):4130-63. PubMed ID: 15954154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-protein interactions as targets for small molecule drug discovery.
    Fry DC
    Biopolymers; 2006; 84(6):535-52. PubMed ID: 17009316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural proteomics in drug discovery.
    Tari LW; Rosenberg M; Schryvers AB
    Expert Rev Proteomics; 2005 Aug; 2(4):511-9. PubMed ID: 16097885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions.
    Huber W
    J Mol Recognit; 2005; 18(4):273-81. PubMed ID: 15997470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are MAP kinases drug targets? Yes, but difficult ones.
    Margutti S; Laufer SA
    ChemMedChem; 2007 Aug; 2(8):1116-40. PubMed ID: 17541990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural genomics and drug discovery: all in the family.
    Weigelt J; McBroom-Cerajewski LD; Schapira M; Zhao Y; Arrowsmith CH
    Curr Opin Chem Biol; 2008 Feb; 12(1):32-9. PubMed ID: 18282486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From targets to leads: the importance of advanced data analysis for decision support in drug discovery.
    Fischer HP; Heyse S
    Curr Opin Drug Discov Devel; 2005 May; 8(3):334-46. PubMed ID: 15892249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.